These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Diabetes-associated cognitive impairment is improved by a calcium channel blocker, nifedipine. Tsukuda K, Mogi M, Li JM, Iwanami J, Min LJ, Sakata A, Fujita T, Iwai M, Horiuchi M. Hypertension; 2008 Feb 31; 51(2):528-33. PubMed ID: 18195165 [Abstract] [Full Text] [Related]
52. Neurokinin-1 receptor inhibition reverses ischaemic brain injury and dementia in bilateral common carotid artery occluded rats: possible mechanisms. Kaur J, Sharma S, Sandhu M, Sharma S. Inflammopharmacology; 2016 Aug 25; 24(4):133-43. PubMed ID: 27380492 [Abstract] [Full Text] [Related]
53. Possible role of endothelin receptor against hyperhomocysteinemia and β-amyloid induced AD type of vascular dementia in rats. Singh M, Prakash A. Brain Res Bull; 2017 Jul 25; 133():31-41. PubMed ID: 28274813 [Abstract] [Full Text] [Related]
57. Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease. Gupta R, Gupta LK. Pharmacol Biochem Behav; 2012 Aug 25; 102(2):184-90. PubMed ID: 22503969 [Abstract] [Full Text] [Related]
58. Protective Effects of Pioglitazone on Cognitive Impairment and the Underlying Mechanisms: A Review of Literature. Alhowail A, Alsikhan R, Alsaud M, Aldubayan M, Rabbani SI. Drug Des Devel Ther; 2022 Aug 25; 16():2919-2931. PubMed ID: 36068789 [Abstract] [Full Text] [Related]
59. Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer's disease. Jayant S, Sharma BM, Bansal R, Sharma B. Pharmacol Biochem Behav; 2016 Jan 25; 140():39-50. PubMed ID: 26577751 [Abstract] [Full Text] [Related]